Vampirinip III

Vampirinip III Brand names, Vampirinip III Analogs

Vampirinip III Brand Names Mixture

No information avaliable

Vampirinip III Chemical_Formula

C₁₉H₁₆O₄

Vampirinip III RX_link

http://www.rxlist.com/cgi/generic/warfarin.htm

Vampirinip III fda sheet

Vampirinip_III FDA

Vampirinip III msds (material safety sheet)

Vampirinip_III MSDS

Vampirinip III Synthesis Reference

Stahmann, et al., U.S. Pat. 2,427,578 (1947)

Vampirinip III Molecular Weight

308.328 g/mol

Vampirinip III Melting Point

161 ^oC

Vampirinip III H₂O Solubility

17 mg/L

Vampirinip III State

Solid

Vampirinip III LogP

3.505

Vampirinip III Dosage Forms

Powder for solution; Tablet

Vampirinip III Indication

For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.

Vampirinip III Pharmacology

Warfarin, a coumarin anticoagulant, is a racemic mixture of two active isomers. It is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).

Vampirinip III Absorption

No information avaliable

Vampirinip III side effects and Toxicity

LD₅₀=374 (orally in mice)

Vampirinip III Patient Information